Differentiating aggressive vs. non-aggressive prostate cancer: the MiCheck GPC1 biomarker test
The addition of a new prostate cancer diagnostic test to inform clinicians and patients prior to the decision to biopsy would be beneficial, in conjunction with the traditional measures of PSA and DRE...
Author: VJOncology
Added: 02/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts